Hematological prospect in 1981, particularly in the field of coagulation and fibrinolysis.
D000990:Antithrombin III / Q000502:physiology; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D001920:Bradykinin / Q000502:physiology; D005174:Factor XII / Q000502:physiology; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D007610:Kallikreins / Q000502:physiology; D008297:Male; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors; D015849:Plasminogen Inactivators; D011288:Prekallikrein / Q000502:physiology; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin / Q000502:physiology
D001779:Blood Coagulation Factors; D015849:Plasminogen Inactivators; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; D000990:Antithrombin III; D005174:Factor XII; D011288:Prekallikrein; D007610:Kallikreins; D010960:Plasminogen Activators; D001920:Bradykinin